Related Experiment Video

Updated: Jun 27, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

24.7K

Public-Private Partnership for Treatment of Congenital Heart Diseases: Experiences From an Indian State

Debasis Das1, Nilanjan Dutta1, Shubhadeep Das2

  • 1Departments of Cardiac Surgery, Narayana Superspeciality Hospital, Howrah, India.

World Journal for Pediatric & Congenital Heart Surgery
|January 24, 2024
PubMed

Insights

A public-private partnership in West Bengal, India, successfully treated 27,844 children with congenital heart disease (CHD) through the Sishu Sathi Scheme, improving access to essential cardiac care.

Area of Science:

  • Cardiology
  • Public Health
  • Health Economics

Background:

  • Congenital heart disease (CHD) is a leading cause of infant mortality and poses a significant financial burden in low- and middle-income countries (LMICs).
  • Effective treatment strategies for CHD are crucial for reducing mortality and improving long-term outcomes in vulnerable populations.
  • Public-private partnerships (PPPs) offer a potential model for addressing healthcare access and affordability challenges in LMICs.

Purpose of the Study:

  • To evaluate the effectiveness and outcomes of a public-private partnership (PPP) model for treating congenital heart disease (CHD) in West Bengal, India.
  • To assess the impact of the 'Sishu Sathi Scheme' on providing free cardiac treatment to children.
  • To analyze the feasibility and scalability of PPPs for managing CHD in resource-limited settings.

Main Methods:

  • The study analyzed data from the 'Sishu Sathi Scheme,' a government-led initiative in West Bengal, India, from 2013 to 2022.
  • Treatment was delivered through a reimbursement model involving selected private and public hospitals.
  • Data included patient demographics, types of procedures (device interventions, cardiac catheterizations, surgical interventions), and in-hospital mortality rates.

Main Results:

  • A total of 27,844 children with CHD received treatment between August 2013 and December 2022.
  • From January 2016 to December 2022, 22,572 procedures were performed, including 11,483 surgeries and 6,249 device interventions.
  • In-hospital mortality rates were 5.2% for surgical procedures and 0.9% for catheterization lab procedures.

Conclusions:

  • The public-private partnership model, exemplified by the 'Sishu Sathi Scheme,' has successfully expanded access to congenital heart disease treatment in West Bengal.
  • This PPP approach demonstrates significant potential for addressing the challenges of access and affordability in CHD care within LMICs.
  • The model provides a scalable framework for improving pediatric cardiac surgery outcomes in resource-constrained healthcare systems.

Keywords:
Congenital heart diseasehealth economicshealth policyhealth provider payments

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.6K
Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training09:15

Creation of Patient-Specific Silicone Cardiac Models with Applications in Pre-surgical Plans and Hands-on Training

Published on: February 10, 2022

3.5K

Related Concept Videos

Primary Healthcare Services01:30

Primary Healthcare Services

Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Secondary Healthcare System01:11

Secondary Healthcare System

Secondary healthcare is offered by a specialist, generally in hospitals or clinics for patients referred by primary healthcare providers. It occurs when a person has an illness or injury that requires specific medical care. Secondary care is often referred to as acute care. Secondary care can range from uncomplicated care to repair a minor laceration or treat a strep throat infection to more complicated emergent care, such as treating a head injury sustained in an automobile accident. Whatever...
Tertiary Healthcare System01:21

Tertiary Healthcare System

Specialized care provided over an extended period is called tertiary care. Usually, a primary or secondary care physician will refer a patient to tertiary care. A patient's maximum physical and mental function is restored in tertiary care, which is caused due to the impact of a chronic illness or condition. Tertiary care aims to achieve the highest level of functioning possible while managing chronic illness. For example, a patient who falls and fractures their hip will need secondary care to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...